Case number 1:23-cv-00548
Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2023 | 9 | STIPULATION TO EXTEND TIME Alembic to answer, move or otherwise respond to the Complaint to June 28, 2023 - filed by Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gattuso, Dominick) (Entered: 06/20/2023) (2) |
| May 25, 2023 | 8 | STIPULATION and [Proposed] Order Regarding Service of Complaint Against Alembic and Case Consolidation by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals, LP, AstraZeneca UK Limited, Merck Sharp & Dohme B.V., AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) (Entered: 05/25/2023) (4) |
| May 19, 2023 | 1 | Complaint* (1) |
| May 19, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 05/19/2023) (3) |
| May 19, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 5, 2023. Date of Expiration of Patent: January 21, 2035.Thirty Month Stay Deadline: 4/30/2025. (jfm) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (jfm) (Entered: 05/19/2023) (1) |
| May 19, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Limited filed by Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited(jfm) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co. for Merck Sharp & Dohme B.V. filed by Merck Sharp & Dohme B.V. (jfm) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 7 | Summons Issued as to Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. on 5/19/2023. (Attachments: # 1 Summons Issued Alembic Pharmaceuticals, Inc.)(jfm) (Entered: 05/19/2023) (Main Document) (2) |
| May 19, 2023 | 7 | Summons Issued as to Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc. on 5/19/2023. (Attachments: # 1 Summons Issued Alembic Pharmaceuticals, Inc.)(jfm) (Entered: 05/19/2023) (Summons Issued Alembic Pharmaceuticals, Inc.) (2) |
